The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oligonucleotide Market Research Report 2024
Synopsis
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
The global Oligonucleotide market was valued at US$ 1254 million in 2023 and is anticipated to reach US$ 2493.1 million by 2030, witnessing a CAGR of 10.1% during the forecast period 2024-2030.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide.
Report Scope
The Oligonucleotide market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Oligo Factory
Danaher
Thermo Fisher Scientific
GE
Merck
Eurofins Scientific
Agilent
SUMITOMO CHEMICAL
Bachem
Sylentis
Segment by Type
DNA
RNA
Segment by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oligonucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oligonucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oligonucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
The global Oligonucleotide market was valued at US$ 1254 million in 2023 and is anticipated to reach US$ 2493.1 million by 2030, witnessing a CAGR of 10.1% during the forecast period 2024-2030.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide.
Report Scope
The Oligonucleotide market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Oligo Factory
Danaher
Thermo Fisher Scientific
GE
Merck
Eurofins Scientific
Agilent
SUMITOMO CHEMICAL
Bachem
Sylentis
Segment by Type
DNA
RNA
Segment by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oligonucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Oligonucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Oligonucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Oligonucleotide Market Overview
1.1 Product Definition
1.2 Oligonucleotide Segment by Type
1.2.1 Global Oligonucleotide Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 DNA
1.2.3 RNA
1.3 Oligonucleotide Segment by Application
1.3.1 Global Oligonucleotide Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Gene Chip
1.3.3 Electrophoresis
1.3.4 Fluorescence In Situ Hybridization
1.4 Global Market Growth Prospects
1.4.1 Global Oligonucleotide Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Oligonucleotide Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Oligonucleotide Production Estimates and Forecasts (2019-2030)
1.4.4 Global Oligonucleotide Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oligonucleotide Production Market Share by Manufacturers (2019-2024)
2.2 Global Oligonucleotide Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Oligonucleotide, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Oligonucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Oligonucleotide Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Oligonucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oligonucleotide, Product Offered and Application
2.8 Global Key Manufacturers of Oligonucleotide, Date of Enter into This Industry
2.9 Oligonucleotide Market Competitive Situation and Trends
2.9.1 Oligonucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oligonucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oligonucleotide Production by Region
3.1 Global Oligonucleotide Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Oligonucleotide Production Value by Region (2019-2030)
3.2.1 Global Oligonucleotide Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Oligonucleotide by Region (2025-2030)
3.3 Global Oligonucleotide Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Oligonucleotide Production by Region (2019-2030)
3.4.1 Global Oligonucleotide Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Oligonucleotide by Region (2025-2030)
3.5 Global Oligonucleotide Market Price Analysis by Region (2019-2024)
3.6 Global Oligonucleotide Production and Value, Year-over-Year Growth
3.6.1 North America Oligonucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Oligonucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Oligonucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Oligonucleotide Production Value Estimates and Forecasts (2019-2030)
4 Oligonucleotide Consumption by Region
4.1 Global Oligonucleotide Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Oligonucleotide Consumption by Region (2019-2030)
4.2.1 Global Oligonucleotide Consumption by Region (2019-2024)
4.2.2 Global Oligonucleotide Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Oligonucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Oligonucleotide Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oligonucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Oligonucleotide Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oligonucleotide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Oligonucleotide Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oligonucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Oligonucleotide Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Oligonucleotide Production by Type (2019-2030)
5.1.1 Global Oligonucleotide Production by Type (2019-2024)
5.1.2 Global Oligonucleotide Production by Type (2025-2030)
5.1.3 Global Oligonucleotide Production Market Share by Type (2019-2030)
5.2 Global Oligonucleotide Production Value by Type (2019-2030)
5.2.1 Global Oligonucleotide Production Value by Type (2019-2024)
5.2.2 Global Oligonucleotide Production Value by Type (2025-2030)
5.2.3 Global Oligonucleotide Production Value Market Share by Type (2019-2030)
5.3 Global Oligonucleotide Price by Type (2019-2030)
6 Segment by Application
6.1 Global Oligonucleotide Production by Application (2019-2030)
6.1.1 Global Oligonucleotide Production by Application (2019-2024)
6.1.2 Global Oligonucleotide Production by Application (2025-2030)
6.1.3 Global Oligonucleotide Production Market Share by Application (2019-2030)
6.2 Global Oligonucleotide Production Value by Application (2019-2030)
6.2.1 Global Oligonucleotide Production Value by Application (2019-2024)
6.2.2 Global Oligonucleotide Production Value by Application (2025-2030)
6.2.3 Global Oligonucleotide Production Value Market Share by Application (2019-2030)
6.3 Global Oligonucleotide Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Abbott Molecular
7.1.1 Abbott Molecular Oligonucleotide Corporation Information
7.1.2 Abbott Molecular Oligonucleotide Product Portfolio
7.1.3 Abbott Molecular Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Abbott Molecular Main Business and Markets Served
7.1.5 Abbott Molecular Recent Developments/Updates
7.2 PerkinElmer
7.2.1 PerkinElmer Oligonucleotide Corporation Information
7.2.2 PerkinElmer Oligonucleotide Product Portfolio
7.2.3 PerkinElmer Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.2.4 PerkinElmer Main Business and Markets Served
7.2.5 PerkinElmer Recent Developments/Updates
7.3 SciGene Corporation
7.3.1 SciGene Corporation Oligonucleotide Corporation Information
7.3.2 SciGene Corporation Oligonucleotide Product Portfolio
7.3.3 SciGene Corporation Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.3.4 SciGene Corporation Main Business and Markets Served
7.3.5 SciGene Corporation Recent Developments/Updates
7.4 Roche NimbleGen
7.4.1 Roche NimbleGen Oligonucleotide Corporation Information
7.4.2 Roche NimbleGen Oligonucleotide Product Portfolio
7.4.3 Roche NimbleGen Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Roche NimbleGen Main Business and Markets Served
7.4.5 Roche NimbleGen Recent Developments/Updates
7.5 CytoTest
7.5.1 CytoTest Oligonucleotide Corporation Information
7.5.2 CytoTest Oligonucleotide Product Portfolio
7.5.3 CytoTest Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.5.4 CytoTest Main Business and Markets Served
7.5.5 CytoTest Recent Developments/Updates
7.6 Oligo Factory
7.6.1 Oligo Factory Oligonucleotide Corporation Information
7.6.2 Oligo Factory Oligonucleotide Product Portfolio
7.6.3 Oligo Factory Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Oligo Factory Main Business and Markets Served
7.6.5 Oligo Factory Recent Developments/Updates
7.7 Danaher
7.7.1 Danaher Oligonucleotide Corporation Information
7.7.2 Danaher Oligonucleotide Product Portfolio
7.7.3 Danaher Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Danaher Main Business and Markets Served
7.7.5 Danaher Recent Developments/Updates
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Oligonucleotide Corporation Information
7.8.2 Thermo Fisher Scientific Oligonucleotide Product Portfolio
7.8.3 Thermo Fisher Scientific Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Thermo Fisher Scientific Main Business and Markets Served
7.7.5 Thermo Fisher Scientific Recent Developments/Updates
7.9 GE
7.9.1 GE Oligonucleotide Corporation Information
7.9.2 GE Oligonucleotide Product Portfolio
7.9.3 GE Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.9.4 GE Main Business and Markets Served
7.9.5 GE Recent Developments/Updates
7.10 Merck
7.10.1 Merck Oligonucleotide Corporation Information
7.10.2 Merck Oligonucleotide Product Portfolio
7.10.3 Merck Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Merck Main Business and Markets Served
7.10.5 Merck Recent Developments/Updates
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Oligonucleotide Corporation Information
7.11.2 Eurofins Scientific Oligonucleotide Product Portfolio
7.11.3 Eurofins Scientific Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Eurofins Scientific Main Business and Markets Served
7.11.5 Eurofins Scientific Recent Developments/Updates
7.12 Agilent
7.12.1 Agilent Oligonucleotide Corporation Information
7.12.2 Agilent Oligonucleotide Product Portfolio
7.12.3 Agilent Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Agilent Main Business and Markets Served
7.12.5 Agilent Recent Developments/Updates
7.13 SUMITOMO CHEMICAL
7.13.1 SUMITOMO CHEMICAL Oligonucleotide Corporation Information
7.13.2 SUMITOMO CHEMICAL Oligonucleotide Product Portfolio
7.13.3 SUMITOMO CHEMICAL Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.13.4 SUMITOMO CHEMICAL Main Business and Markets Served
7.13.5 SUMITOMO CHEMICAL Recent Developments/Updates
7.14 Bachem
7.14.1 Bachem Oligonucleotide Corporation Information
7.14.2 Bachem Oligonucleotide Product Portfolio
7.14.3 Bachem Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Bachem Main Business and Markets Served
7.14.5 Bachem Recent Developments/Updates
7.15 Sylentis
7.15.1 Sylentis Oligonucleotide Corporation Information
7.15.2 Sylentis Oligonucleotide Product Portfolio
7.15.3 Sylentis Oligonucleotide Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Sylentis Main Business and Markets Served
7.15.5 Sylentis Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oligonucleotide Industry Chain Analysis
8.2 Oligonucleotide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oligonucleotide Production Mode & Process
8.4 Oligonucleotide Sales and Marketing
8.4.1 Oligonucleotide Sales Channels
8.4.2 Oligonucleotide Distributors
8.5 Oligonucleotide Customers
9 Oligonucleotide Market Dynamics
9.1 Oligonucleotide Industry Trends
9.2 Oligonucleotide Market Drivers
9.3 Oligonucleotide Market Challenges
9.4 Oligonucleotide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
